Supriya Sarkar, PhD, MPH

Director, Epidemiology and Real World Evidence
ViiV Healthcare

Disclosure(s): ViiV Healthcare: Stocks/Bonds (Public Company)

Poster(s):

• (P-300) Characteristics associated with HIV pre-exposure prophylaxis persistence among men who have sex with men in the United States: results from the American Men’s Internet Survey (AMIS) 2023-24
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-306) Associations between Intersectional Stigma and Long-Acting Injectable PrEP (LAI-PrEP) Willingness and Preference among Gay, Bisexual, and other Men who have Sex with Men (GBMSM)
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-332) Screening Practices for HIV and Sexually Transmitted Infections During Cabotegravir Long Acting or Daily Oral Pre-Exposure Prophylaxis Use in the US
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET